Skip to content
Assyro AI
Purple Book reference family · 351(a) biologic

bulevirtide-gmod (Hepcludex)

bulevirtide-gmod is an FDA-licensed reference biologic from Gilead Sciences, Inc..

351(a) biologicBLA 761468 Gilead Sciences, Inc.
Biosimilars
0
Interchangeables
0
Listed patents
0
Reference approved
2026

Reference product

Originator biologic
Ask AI
351(a)BLA 761468

Hepcludex bulevirtide-gmod

Gilead Sciences, Inc.

View full reference-product record
Approved
Marketing
Rx
Center
CDER
Patents
None listed

Exclusivity & patent cliffs

Protection horizon
Ask AI
  1. Reference approval

    Approval date of the reference bulevirtide-gmod product.

    6 mo ago

bulevirtide-gmod: frequently asked questions

Reference exclusivity, biosimilars, interchangeability, and patents for this molecule, from the FDA Purple Book.

Built from official FDA Purple Book records (monthly downloads, the Advanced Search interface, and the published Patent List), with reference-product, license-type, and exclusivity context for bulevirtide-gmod.

Related FDA reference tools

Assyro Intelligence

Ask anything about bulevirtide-gmod

Cited answers from FDA, EMA, Health Canada, PubMed and ClinicalTrials.gov, in seconds. Free, no sign-up.

  • PubMed
  • ClinicalTrials.gov
  • FDA
  • Health Canada
  • EMA
  • ICH

Evaluating for a team? Book a demo